FDA Person
FDASusan M. Jackson
View detailed information about Susan M. Jackson, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 43 inspections of 41 companies, 2016–2025.
Inspections (43)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| January 31, 2025 | Symbiosis Pharmaceutical Services Limited | Not classified | #1266061 | |
| January 31, 2025 | Symbiosis Pharmaceutical Services Limited | NAI | Human Cellular, Tissue, and Gene Therapies | #1266061 |
| January 21, 2025 | Roslin Cell Therapies Limited | VAI | Human Cellular, Tissue, and Gene Therapies | #1258906 |
| November 22, 2024 | Bioreliance Corporation | VAI | Vaccine, Allergenic, and Live Biotherapeutic Products | #1254934 |
| August 28, 2024 | Charles River Laboratories France CRLF | NAI | Vaccines and Allergenic Products | #1253121 |
| August 16, 2024 | SmartPractice Denmark ApS | NAI | Vaccines and Allergenic Products | #1253548 |
| June 21, 2024 | Sanofi S.r.l. | NAI | Blood and Blood Products | #1234890 |
| June 11, 2024 | Octapharma Produktionsgesellschaft Deutschland mbH | VAI | Blood and Blood Products | #1240862 |
| March 22, 2024 | Novartis Pharmaceutical Manufacturing GmbH | Not classified | #1249686 | |
| March 12, 2024 | GlaxoSmithKline Biologicals | VAI | Vaccines and Allergenic Products | #1232702 |
| January 26, 2024 | Sanofi Winthrop Industrie | VAI | Vaccines and Allergenic Products | #1227792 |
| January 12, 2024 | Sanofi Winthrop Industrie | NAI | Vaccines and Allergenic Products | #1232740 |
| November 17, 2023 | Instituto Grifols, S.A. | VAI | Blood and Blood Products | #1223732 |
| November 7, 2023 | Hospira Zagreb d.o.o. | NAI | Vaccines and Allergenic Products | #1225278 |
| August 10, 2023 | Dendreon Pharmaceuticals LLC | VAI | Human Cellular, Tissue, and Gene Therapies | #1214688 |
| May 26, 2023 | Seqirus Vaccines Limited | VAI | Vaccines and Allergenic Products | #1206283 |
| May 16, 2023 | Pfizer Manufacturing Belgium NV | Not classified | #1214848 | |
| April 26, 2023 | Merck Sharp & Dohme LLC | NAI | Vaccines and Allergenic Products | #1210555 |
| February 3, 2023 | Dynavax GmbH | VAI | Vaccines and Allergenic Products | #1201864 |
| January 24, 2023 | Pfizer Ireland Pharmaceuticals Unlimited Company | Not classified | #1201722 |
Documents (39)
- EIR · Pfizer Manufacturing Belgium NV · July 2, 2021
- 483 · Sanofi Vaccines US Inc. · January 26, 2024
- EIR · AndersonBrecon Inc. · December 5, 2018
- 483 · Roslin Cell Therapies Limited · January 21, 2025
- 483 · MassBiologics
- 483 · Micro Typing Systems, Inc. · December 10, 2019
- EIR · Novartis Pharmaceuticals Corporation · August 21, 2019
- EIR · Minaris Regenerative Medicine, LLC · April 26, 2017
- 483 · CSL Behring (Australia) Pty Ltd · March 8, 2022
- 483 · Bioreliance Corporation · November 22, 2024
- 483 · Grifols Therapeutics LLC
- 483 · Dendreon Pharmaceuticals LLC · August 10, 2023
- 483 · ENDO USA, Inc. · October 18, 2021
- 483 · Biogen MA Inc. · March 23, 2017
- 483 · Sanofi Winthrop Industrie · January 26, 2024
- 483 · FinVector Oy
- EIR · Seqirus Inc · June 9, 2022
- 483 · Baxter Pharmaceutical Solutions, LLC
- EIR · NOVA LABORATORIES LIMITED · March 12, 2019
- 483 · Laboratorios L.O. Oftalmi, C.A.
- 483 · Sanofi Pasteur Limited
- 483 · Micro Typing Systems, Inc. · November 22, 2021
- 483 · LifeSouth Community Blood Centers, Inc
- EIR · Bioreliance Corporation · July 13, 2018
- 483 · Seqirus Inc
- 483 · GlaxoSmithKline Biologicals SA · June 24, 2019
- 483 · Novartis Pharmaceuticals Corporation · August 21, 2019
- 483 · Kedrion Biopharma Inc. · June 25, 2021
- 483 · Octapharma Produktionsgesellschaft Deutschland mbH · June 11, 2024
- 483 · Merck Sharp & Dohme LLC
- EIR · Grifols Therapeutics LLC · May 6, 2022
- 483 · GlaxoSmithKline Biologicals · March 12, 2024
- 483 · Seqirus Vaccines Limited · May 26, 2023
- 483 · Dynavax GmbH
- 483 · Instituto Grifols, S.A. · November 17, 2023
- 483 · MassBiologics · November 19, 2019
- EIR · Unknown Company · May 4, 2022
- 483 · Prothya Biosolutions Belgium
- 483 · Hisun Pharmaceutical (Nantong) Co., Ltd. · July 12, 2024
Frequently inspected with (10)
Debra M. Emerson
Strategic Expert at NovoNordisk; Retired from FDA
5 shared
Cynthia Jim
3 shared
Latorie S. Jones
Consumer Safety Officer at Commissioned Corps of the U.S. Public Health Service
3 shared
Thai D. Truong
Investigator
3 shared
Gene D. Arcy
2 shared
Jacqueline M. Diaz Albertini
investigator
2 shared
Laurel A. Beer
2 shared
Leslie D. Wagner
2 shared
Lewis K. Antwi
2 shared
Mihaly S. Ligmond
CSO
2 shared
Person Information
Name
Susan M. Jackson
Title
investigator
Role
ISSUING OFFICER
ID: 2a4e01d1-8761-4d40-b493-69a4163473bb
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.